- Summary
- Table Of Content
- Methodology
ePedigree Software Market Size:
ePedigree Software Market size is estimated to reach over USD 13.53 Billion by 2032 from a value of USD 5.71 Billion in 2024 and is projected to grow by USD 6.26 Billion in 2025, growing at a CAGR of 12.7% from 2025 to 2032.
ePedigree Software Market Scope & Overview:
ePedigree software refers to electronic software solutions that facilitate the tracking and tracing of pharmaceutical products throughout the supply chain, from manufacturing to the end user. These systems ensure the authenticity and safety of drugs by providing an auditable record of each transaction and movement of a specific batch or product. This software enables manufacturers, distributors, and pharmacies to track the journey of a drug, from its origin to the final point of distribution.
ePedigree Software Market Dynamics - (DRO) :
Key Drivers:
Rising adoption of ePedigree software in supply chain management is boosting the market growth
ePedigree software is a crucial component of pharmaceutical supply chain management, focusing on traceability and authenticity of drugs throughout the supply chain, from manufacturing to the pharmacy. It helps ensure that patients receive genuine medications by providing information on the movement of each drug product and its lineage. ePedigree systems are often integrated with ERP platforms and utilize technologies like serialization and EPCIS databases to track product information.
- For instance, Barcode Integrators offers ePedigree Track and Trace. It provides improved inventory and returns processing, improved efficiency, and reduced costs.
Thus, the market analysis depicts that the aforementioned factors are boosting the adoption of this software, in turn driving the ePedigree software market growth.
Key Restraints:
Risks associated with data breaches and cyberattacks are hindering the market growth
E-pedigree software, used for tracking pharmaceutical supply chains, is vulnerable to data breaches and cyberattacks due to its reliance on technology and data sharing. These attacks can compromise patient safety, disrupt operations, and lead to significant financial and reputational damage.
Additionally, e-pedigree systems are often built using third-party software and libraries, making them susceptible to supply chain attacks. A vulnerability in one component can expose the entire system. Thus, the market analysis shows that the aforementioned factors are restraining the ePedigree software market demand.
Future Opportunities :
Integration of cloud computing with ePedigree software is expected to create new market opportunities
ePedigree software leverages cloud computing for various benefits, including scalability, cost-effectiveness, and enhanced data management, particularly for pharmaceutical companies that need to comply with DSCSA guidelines. Cloud platforms like ePedigree allow dynamic features and improved efficiency in data management and process streamlining. Cloud platforms offer the flexibility to scale up or down as needed, accommodating fluctuating business demands. Thus, the market analysis depicts that the ongoing advancements in software are projected to drive the ePedigree software market opportunities during the forecast period.
ePedigree Software Market Segmental Analysis :
By Component:
Based on the component, the market is segmented into software and services.
Trends in the Component:
- Rising adoption of epedigree software for preventing counterfeit drugs, improving supply chain visibility, and enhancing patient safety by tracking medication distribution and usage.
- Increasing trend in adoption of ePedigree services to track the history of a drug batch, ensuring transparency and consumer protection against counterfeit or contaminated medications.
The software segment accounted for the largest revenue share in the ePedigree software market share in 2024.
- E-pedigree software is used in the pharmaceutical industry to create and manage electronic records that track the history of a drug, including each sale, purchase, and trade.
- These records are known as e-pedigrees and are designed to protect consumers from counterfeit or contaminated drugs.
- The software ensures an auditable and traceable record of a drug's journey from the manufacturer to the end user.
- This software often integrates with other systems, such as ERP (enterprise resource planning) systems, to ensure a seamless flow of information.
- For instance, Progeny Genetics LLC offers pedigree software for clinicians. It allows a simpler process for managing family health history, assessing risk, and evaluating treatment options for patients.
- Therefore, the market analysis depicts that the widespread adoption of e-pedigree software is boosting the ePedigree software market growth.
The services segment is expected to register the fastest CAGR during the forecast period.
- By tracking the product's history, ePedigree systems help prevent the sale of counterfeit drugs.
- They provide a clear record of the drug's origin and movement, which is crucial for ensuring product safety and quality.
- ePedigree systems can streamline supply chain operations by providing real-time visibility into product movement.
- By tracking product movement, ePedigree systems help reduce waste and improve inventory management.
- Moreover, ePedigree systems provide valuable information for locating affected products.
- Thus, the market analysis depicts that the rising demand for ePedigree services is expected to boost the ePedigree software market trends during the forecast period.
By Deployment Mode:
Based on the deployment mode, the market is segmented into on-premise and cloud.
Trends in the Deployment Mode:
- Rising demand for on-premise deployment in organizations to maintain full control over their data, and ensure they meet specific regulatory requirements.
- Increasing trend in the adoption of cloud deployment for scalability and flexibility is boosting the ePedigree software market size.
The cloud segment accounted for the largest revenue share in the market in 2024, and it is expected to register the fastest CAGR during the forecast period.
- Cloud deployment of software offers numerous benefits, including cost savings, increased flexibility and scalability, faster deployment times, enhanced security, and improved disaster recovery. It also facilitates better collaboration and data sharing.
- Cloud deployment streamlines the development and deployment process, enabling businesses to get new software and features to market faster.
- Cloud service providers invest heavily in security measures, including firewalls, intrusion detection systems, and data encryption, to protect sensitive data and applications.
- Cloud-based applications enable teams to collaborate seamlessly and share data in real-time, regardless of location.
- For instance, DCAA Solutions offers ePedigreeRX, a cloud-based solution for pharmaceutical wholesalers. The solution offers streamlined workflows, full traceability, and robust security for the supply chain.
- Thus, the rising adoption of cloud-based software is boosting the ePedigree software market opportunities during the forecast period.
By Application:
Based on the application, the market is segmented into hospital pharmacies, retail pharmacies, pharmaceutical factory, online pharmacies, and others.
Trends in the Application:
- Rising adoption of ePedigree solutions in retail pharmacies for tracking the movement of prescription drugs from manufacturer to consumer to combat counterfeit and adulterated medications is propelling the ePedigree software market size.
- Increasing trend in adoption of ePedigree to track and trace pharmaceutical products throughout the supply chain, ensuring authenticity and preventing forged drugs.
The hospital pharmacies segment accounted for the largest revenue share of 39.53% in the ePedigree software market share in 2024.
- Integrating ePedigree software into a hospital pharmacy system offers several benefits, which includes on enhanced patient safety, regulatory compliance, and operational efficiency.
- It streamlines prescription management, minimizes medication errors, and improves overall workflow, ultimately contributing to better healthcare delivery.
- ePedigree systems integrate with pharmacy systems, allowing real-time verification of prescriptions. This eliminates communication errors and helps ensure that patients receive the correct medication in the right dosage.
- Therefore, the aforementioned factors are boosting the ePedigree software market expansion.
The online pharmacies segment is expected to register the fastest CAGR during the forecast period.
- ePedigree software, in conjunction with online pharmacies, offers benefits such as improved drug supply chain security, reduced counterfeiting risk, and enhanced efficiency in tracking and managing medication distribution.
- These systems ensure authenticity and traceability, ultimately protecting patients from potentially harmful drugs.
- Additionally, online pharmacies provide convenient and cost-effective access to medications, particularly for those with limited mobility or those seeking privacy.
- Thus, the aforementioned factors are expected to drive the ePedigree software market trends during the forecast period.
Regional Analysis:
The regions covered are North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
Asia Pacific region was valued at USD 1.51 Billion in 2024. Moreover, it is projected to grow by USD 1.66 Billion in 2025 and reach over USD 3.69 Billion by 2032. Out of this, China accounted for the maximum revenue share of 33.26%. The ePedigree software market analysis depicts that the market growth in the region is driven by the growing pharmaceutical industry due to the huge population, medicine advancements, and others. Moreover, countries including China, India, and Australia are actively implementing these systems to detect forged drugs and ensure the quality of pharmaceuticals.
- For instance, according to the Ministry of Chemicals and Fertilizers, India, the Indian pharmaceuticals industry is the third largest in the world by volume. Moreover, the industry is the 14th largest in the world by production. The above factors are driving the market growth in the Asia-Pacific region.
North America is estimated to reach over USD 4.50 Billion by 2032 from a value of USD 1.91 Billion in 2024 and is projected to grow by USD 2.09 Billion in 2025. The market growth in the region is primarily driven by the well-established pharmaceutical sector. Moreover, regulatory bodies United States Food and Drug Administration (FDA), are implementing stricter measures to combat drug diversion and ensure the safety of the supply chain.
- For instance, in 2023, the FDA approved 55 novel drugs in the U.S. This is further increasing the adoption of ePedigree solutions, in turn propelling the ePedigree software market expansion in the region.
The ePedigree software market analysis depicts that in Europe, the market is primarily driven by rising pharmaceutical production and rising demand for ePedigree services to ensure the integrity, authenticity, and safety of medicines. The market in the Latin America, Middle East, and Africa region is growing due to the growing pharmaceutical sector and increasing development of pharmaceutical manufacturing facilities, in turn leading to the adoption of ePedigree services. Thus, the aforementioned factors are boosting the ePedigree software market demand.
Top Key Players and Market Share Insights:
The ePedigree software industry is highly competitive, with major players providing solutions and services to the national and international markets. Key players are adopting several strategies in research and development (R&D), product innovation, and end-user launches to hold a strong position in the global ePedigree software market. Key players in the ePedigree software industry include -
- Progeny Genetics LLC (US)
- Wild Systems (Australia)
- Pedigree Technologies (US)
- CeGaT GmbH (Germany)
- Grassroots Systems (India)
- Tenset (UK)
- ZooEasy (Netherlands)
- Siemens AG (Germany)
- TrakGene (Australia)
ePedigree Software Market Report Insights :
| Report Attributes | Report Details |
| Study Timeline | 2019-2032 |
| Market Size in 2032 | USD 13.53 Billion |
| CAGR (2025-2032) | 12.7% |
| By Component |
|
| By Deployment Type |
|
| By Application |
|
| By End User |
|
| By Region |
|
| Key Players |
|
| North America | U.S. Canada Mexico |
| Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
| APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
| Middle East and Africa | GCC Turkey South Africa Rest of MEA |
| LATAM | Brazil Argentina Chile Rest of LATAM |
| Report Coverage |
|
Key Questions Answered in the Report
How big is the ePedigree software market? +
ePedigree Software Market size is estimated to reach over USD 13.53 Billion by 2032 from a value of USD 5.71 Billion in 2024 and is projected to grow by USD 6.26 Billion in 2025, growing at a CAGR of 12.7% from 2025 to 2032.
What are the major segments covered in the ePedigree software market report? +
The segments covered in the report are component, deployment type, application, and region.
Which region holds the largest revenue share in 2024 in the ePedigree software market? +
North America holds the largest revenue share in the ePedigree software market in 2024.
Who are the major key players in the ePedigree software market? +
The major key players in the market are Progeny Genetics LLC (US), Wild Systems (Australia), Pedigree Technologies (US), CeGaT GmbH (Germany), Grassroots Systems (India), Tenset (UK), ZooEasy (Netherlands), Siemens AG (Germany), TrakGene (Australia), and others.
